Statistics for Scleromyxedema with neurologic involvement: Therapy with intravenous immunoglobulin
Total visits
views | |
---|---|
Scleromyxedema with neurologic involvement: Therapy with intravenous immunoglobulin | 227 |
Total visits per month
views | |
---|---|
December 2024 | 1 |
January 2025 | 0 |
February 2025 | 1 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
Scleromyxedema with neurologic involvement.pdf(legacy) | 484 |
Scleromyxedema with neurologic involvement.pdf | 6 |
Crescemos juntos - pp. 22-37.pdf(legacy) | 1 |
Projecto_Final27102014_FINAL.pdf(legacy) | 1 |
Logo_horizontal_ESEP_300.png(legacy) | 1 |
Ricardo-Jorge-Lopes-2.ANEXO-Manual-Utilizador-Web-v1.pdf(legacy) | 1 |
PatríciaRodrigues.pdf(legacy) | 1 |
Relatório_Ana Pena.pdf(legacy) | 1 |
ESSTFC599.pdf(legacy) | 1 |
JorgeVOetal2004.pdf(legacy) | 1 |
Top country views
views | |
---|---|
United States | 132 |
China | 34 |
Portugal | 21 |
France | 7 |
Germany | 5 |
United Kingdom | 5 |
Russia | 4 |
Netherlands | 3 |
Brazil | 2 |
Poland | 2 |
A2 | 1 |
Canada | 1 |
European Union | 1 |
Guatemala | 1 |
Mozambique | 1 |
Singapore | 1 |
Ukraine | 1 |